Professor Carolyn Taylor
Carolyn Taylor
BM BCh (oxon) MA MRCP FRCR DPhil
Professor of oncology, Honorary consultant oncologist
Carolyn Taylor is a consultant clinical oncologist and professor of oncology. She studied medicine at Oxford University. Her clinical training was in general medicine and then clinical oncology. She gained Fellowship of the Royal College of Radiologists in 2004.
Since then she has worked as a clinical research fellow at the the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), doing research alongside clinical work. She completed her DPhil on the risk of heart disease after breast cancer radiotherapy in 2008.
She now provides clinical leadership in large international collaborations including oncologists, epidemiologists, statisticians and cancer registry staff.
She works in the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) on trials of surgery and radiotherapy.
She is Principal Investigator on a Cancer Research UK research program on the benefits and risks of cancer treatments. This programme combines information from high quality datasets to produce estimates of benefits and risks for use by oncologists in the clinic today.
Recent publications
Real-world heart and lung doses from 30 000 National Health Service radiotherapy treatment plans in England: a national audit of breast radiotherapy practice.
Journal article
Kirby AM. et al, (2026), Lancet Oncol
Effects of ovarian ablation or suppression on breast cancer recurrence and survival: patient-level meta-analysis of 15 000 women in 23 randomised trials.
Journal article
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Electronic address: bc.overview@ndph.ox.ac.uk . and Early Breast Cancer Trialists' Collaborative Group (EBCTCG) ., (2026), Lancet, 407, 1699 - 1711
Histological types of invasive breast cancer in 830,000 women diagnosed in England during 1988-2016.
Journal article
Probert J. et al, (2025), J Pathol Clin Res, 11
Histological types of invasive breast cancer in 830,000 women diagnosed in England during 1988–2016
Conference paper
Probert J. et al, (2025), Journal of Pathology Clinical Research, 11
Patients need information on the risk of second cancer after early breast cancer.
Journal article
MacKenzie M. et al, (2025), BMJ, 390
